AI-Generated Summary

This article advocates for the upcoming EU Biotech Act as a critical legislative tool to overcome fragmented regulation and bolster Europe's biotechnology sector. It highlights biotech's economic importance and strategic role, arguing that the Act must deliver tangible outcomes like accelerated therapy access, resilient supply chains, and increased investment to secure Europe's global leadership in innovation.

In a nutshell

This analysis offers crucial insight for pharmaceutical executives, investors, and policymakers into the potential impact of the EU Biotech Act. It underscores the high stakes of regulatory reform in shaping Europe's future as a biotech powerhouse and its implications for market dynamics.

Source: Euractiv